about
Phosphate and FGF-23Role of the hexosamine biosynthetic pathway in diabetic nephropathyWhither goest Kt/V?The folate cycle and disease in humansInfluence of polymorphisms in VDR and COLIA1 genes on the risk of osteoporotic fractures in aged menRenal function, protein excretion, and pathology of Balkan endemic nephropathy. IV. ImmunohistologyOrigins and formation of microvasculature in the developing kidneyC-type natriuretic peptide in chronic renal failure and its action in humansAcute renal failure in the folate-treated rat: early metabolic changes in various structures of the nephronLong-term effects of felodipine in patients with reduced renal functionAdrenocorticotrophin and steroid-induced hypertension in humansImmunomodulating properties of 1,25-dihydroxyvitamin D3Folic acid-induced acute renal failure in the the rat: morphological studiesEffect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiableEffect of simvastatin on proliferative nephritis and cell-cycle protein expressionEffect of lipid-lowering strategies on tubular cell biologyDirect inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cellsFunctional analysis and chromosomal gene assignment of rat kidney prostaglandin EP3 receptorAldose reductase and the role of the polyol pathway in diabetic nephropathyGenetic variations associated with diabetic nephropathy and type II diabetes in a Japanese populationTreating azotemia-induced anemia with erythropoietin improves diabetic eye disease.Demographic and epidemiologic transition in the developing world: role of albuminuria in the early diagnosis and prevention of renal and cardiovascular disease.The changing patterns of chronic kidney disease: the need to develop strategies for prevention relevant to different regions and countries.End-stage renal disease in diabetic persons: is the pandemic subsiding?Molecular biology of the renal renin-angiotensin system.Role of angiotensin in renal vascular development.Angiotensin-dependent gene expression in the developing rat kidney.Imaging of hydroperoxides in a rat glomerulus stimulated by puromycin aminonucleoside.Fabry disease: diagnosis and treatment.Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study.Morphology of acute renal failure: comparative data from biopsy and autopsy.Urea-induced inducible nitric oxide synthase inhibition and macrophage proliferation.Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease.Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranes.3-deoxyglucosone and AGEs in uremic complications: inactivation of glutathione peroxidase by 3-deoxyglucosone.Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties.Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils.Advanced glycation end products impair protein turnover in LLC-PK1: amelioration by trypsin.Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure.
P1433
Q24610674-8600475B-2063-4C90-A23D-F6C728985769Q28139160-D3B0EB8C-BC0F-456A-BD2E-46D99B65E188Q28143189-78CCEB47-0BCB-4CCC-9EE9-E4C2E4AC6241Q28199731-5331F9C4-BA7C-4992-AA37-D0878F1357D3Q28204707-DD1AB752-7395-489F-813F-200217E9CDB1Q28236027-2FF6DEF9-22EC-475A-B62C-EB064BB25F09Q28282271-F936F239-B549-4A10-AEF9-BBB680ABA02EQ28286253-CE85529C-FF24-45BB-B859-A225D76F681DQ28319585-E37819E6-D019-4EBA-8F6D-4B11E1781F15Q28320508-F5E18F6D-5579-4ACB-B47D-A53EAB524A14Q28326525-FD91BC10-6B79-41AE-A2D0-1FFFC608CB3CQ28330694-B68902E6-2E51-427E-ACF8-2ACAF0554082Q28336220-E5A86E25-9170-40BB-9EB7-70E6066AB1C0Q28369424-3BBB8405-F227-45DD-A674-6531F095E7E3Q28369427-40B0B921-5244-4D89-8BD3-C408D5E68248Q28369431-F07755ED-9509-4F4D-B3C5-8B2B90A25487Q28369435-AA872436-C3A1-45C2-A744-48CDC5B85C15Q28584084-4D501A05-F871-4DEC-9AEB-858DECC80712Q28645739-17D6F76E-FF9E-4964-AEF8-6C39106D1A4EQ28943528-51A18F39-D6E1-4CAA-992C-6084FEC90E71Q30336156-F0B72895-0B23-4BE6-B400-BE370718ACF1Q30343929-6A5B24E7-272D-4C4C-823F-05AFD2D0CD9FQ30351271-0F35137D-B4E8-4E74-A817-65C0622A8DB3Q30358057-7D8D19DB-88A2-487F-AD93-FB342E649A0CQ30453887-DA7A5AC6-A1A6-4425-BBC9-DDC2A8B7FE1BQ30472568-C021B093-2176-43AA-B1BD-E73F097D23F0Q30472569-2AFA0AEA-32B4-4CB0-A52A-C92286226169Q30738387-0E486F88-07F7-4594-B563-92E501724FB7Q30785476-A8E24E7A-73B7-4F50-96C3-B317F2BF8762Q30785482-43791506-3D51-46B0-9411-CE030FD6E7E6Q31522660-0F7CED2F-8CF8-470B-8378-28C46042BC99Q31904935-CF02C5B4-7E13-4AB5-AFB2-AF8F0F342B93Q31904961-19C26EC4-CC4C-41B8-8D1D-EA8C663EBBC9Q31904987-9CEFE183-E2CC-4B32-BAC3-16AD5E83AD74Q31905012-15D05D88-AD22-4392-95D1-B48A0CEBBA6CQ31905038-1EC77DC5-42D2-4A9E-B883-6E7FA9BA440FQ31905066-7C01E64A-C49F-4C2E-9692-7BED54C907FBQ31905087-FDD279D8-6ED1-4A91-A385-81A7D2CB01F3Q31905118-C7BE8F3B-8306-4162-A33B-0E7239FC845EQ31905145-577AA0F6-4087-46C5-942C-669760FD1343
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Wiley-Blackwell
@nl
wissenschaftliche Fachzeitschrift
@de
name
Kidney international. Supplement
@ast
Kidney international. Supplement
@en
Kidney international. Supplement
@es
Kidney international. Supplement
@it
Kidney international. Supplement
@nl
type
label
Kidney international. Supplement
@ast
Kidney international. Supplement
@en
Kidney international. Supplement
@es
Kidney international. Supplement
@it
Kidney international. Supplement
@nl
prefLabel
Kidney international. Supplement
@ast
Kidney international. Supplement
@en
Kidney international. Supplement
@es
Kidney international. Supplement
@it
Kidney international. Supplement
@nl
P1055
P1156
P123
P1277
P1476
Kidney International. Supplement
@en